Dicerna Pharmaceuticals, Inc.

Dicerna Pharmaceuticals, Inc.

Dicerna, a wholly owned subsidiary of Novo Nordisk, is focused on driving innovation in RNAi (ribonucleic acid interference) to selectively target and silence genes that cause or contribute to disease...

Dicerna Pharmaceuticals, Inc.'s Basic Information

Industry
Pharmaceutical Manufacturing
Headquarters
Lexington, Illinois, United States
Founded Year
2007
Headcount
51 - 200

Dicerna Pharmaceuticals, Inc.'s Competitors

Walgreens Pharmacy
Walgreens Pharmacy

Medicentrum Apotheke
Medicentrum Apotheke

PHARMAZAC SA
PHARMAZAC SA

Athens, Greece

PharmExpand
PharmExpand

France

Balaji Pharmaceutical LTD
Balaji Pharmaceutical LTD

Employee Insights

Employee Function

Employee Location

Dicerna Pharmaceuticals, Inc.'s Top Employees

people
Douglas Fambrough
Founder, President & CEO
people
Lili Yu
Senior Research Associate
people
Siyu Liu
Research Associate
people
Jonathan Dones
Adme Research Associate
people
Pauleon Dinh
Oligonucleotide Synthesis Associate Scientist II

Find Your Next Customer with Better Data

Get access to over 160 million contacts and companies' information in AroundDeal's B2B database, quickly build highly targeted prospect lists and directly reach the buying committee.

Top-ranked on G2 Crowd
🛡️GDPR compliantCancel anytime
Free credits every month!

Frequently Asked Questions Regarding Dicerna Pharmaceuticals, Inc.

Where is Dicerna Pharmaceuticals, Inc.'s headquarter located?

Dicerna Pharmaceuticals, Inc.'s headquarter are located at United States.

How many employees does Dicerna Pharmaceuticals, Inc. have?

Dicerna Pharmaceuticals, Inc. has 51 - 200 employees.

What is Dicerna Pharmaceuticals, Inc.'s official website?

Dicerna Pharmaceuticals, Inc.'s official website is https://www.novonordisk-us.com/careers/find-a-job.html

What industry does Dicerna Pharmaceuticals, Inc. belong to?

Dicerna Pharmaceuticals, Inc. is in the industry of Pharmaceutical Manufacturing

What does Dicerna Pharmaceuticals, Inc. do?

Dicerna, a wholly owned subsidiary of Novo Nordisk, is focused on driving innovation in RNAi (ribonucleic acid interference) to selectively target and silence genes that cause or contribute to disease...

Connect with anyone with AroundDeal today!

Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
cta